8-K: Momentus Amends Equity Deal, Shifts to Variable Share Price

Momentus Inc. has amended its equity purchase agreement with Yield Point NY LLC, changing the share purchase price from a fixed rate to a variable discount based on market trading prices and adjusting put share limits.

Summary

• Momentus Inc. entered into a First Amendment to its Equity Purchase Agreement with Yield Point NY LLC on December 23, 2025.
• The amendment changes the purchase price of Class A common stock from a fixed $1.24 per share to a variable price equal to 94% of the lowest trading price during a three-consecutive-trading-day valuation period.
• The maximum amount of shares deliverable per put exercise is now the lesser of: (a) 75% of the average daily trading volume over the five preceding trading days, (b) 25% of the trading volume on the put date between market opening and put delivery, or (c) 800,000 divided by the last closing price on the put date.
• Yield Point NY LLC waived the timely filing of Momentus's Form 10-Q with the SEC for the quarterly period ending September 30, 2025.
• Momentus is required to file a Form 8-K disclosing this amendment by 9:30 a.m. New York City time on the trading day after the amendment date, and publicly disclose all material non-public information shared with Yield Point.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the shift to less favorable, dilutive financing terms and the investor's waiver of a timely Form 10-Q filing, which suggests potential underlying financial or operational concerns for Momentus Inc.

Positives

• The amendment provides Momentus with continued access to capital through an equity purchase agreement, offering a flexible financing mechanism.
• The agreement allows Momentus to 'put' shares to Yield Point, providing a potential source of liquidity as needed.

Negatives

• The shift from a fixed purchase price of $1.24 per share to a variable price at a 6% discount to the lowest trading price during a three-day period suggests less favorable financing terms for Momentus.
• The variable pricing mechanism introduces uncertainty regarding the capital raised per share and could lead to increased dilution for existing shareholders if the stock price declines.
• Yield Point's waiver of the timely filing of Momentus's Form 10-Q for Q3 2025 raises concerns about the company's financial reporting and operational status.

Risks

• Significant shareholder dilution due to the issuance of shares at a discount to market price under the variable pricing mechanism.
• Increased volatility in the stock price as the market reacts to potential future put exercises and the associated dilution.
• The waiver of the Form 10-Q filing indicates potential financial or operational challenges that could negatively impact investor confidence and stock performance.
• The company's reliance on this financing mechanism could be perceived as a sign of difficulty in securing more traditional or favorable capital.

Future Outlook

The amendment provides Momentus with a revised mechanism for future capital raises through the equity purchase agreement. No specific forward-looking statements regarding operational performance or financial guidance were provided in the filing beyond the terms of this financing agreement.

Management Comments

• John C. Rood, Chief Executive Officer, signed the First Amendment to Equity Purchase Agreement on behalf of Momentus, Inc.
• Lon Ensler, Chief Financial Officer, signed the Form 8-K on behalf of Momentus Inc.

Industry Context

This type of equity line of credit, where shares are sold at a discount to market price, is a common financing mechanism for early-stage or growth companies seeking flexible capital without immediate debt obligations. While providing liquidity, such agreements are often viewed by the market with caution due to the potential for significant shareholder dilution as shares are issued at a discount, particularly if the company's stock price is under pressure.

Comparison to Industry Standards

• This type of equity line of credit, where shares are sold at a discount to market price, is a common financing mechanism for early-stage or growth companies seeking flexible capital without immediate debt obligations.
• While providing liquidity, such agreements are often viewed by the market with caution due to the potential for significant shareholder dilution as shares are issued at a discount.
• No specific comparable companies, projects, or results were mentioned within the filing to provide direct benchmarks.

Corporate Governance

Stakeholder Impact

• Shareholders: Face potential dilution as shares will be issued at a discount to the market price, especially if the stock price declines.
• Investors (Yield Point NY LLC): Gains more favorable terms for future share purchases, allowing them to acquire shares at a discount to market prices.
• Regulatory Authorities (SEC): The waiver of the 10-Q filing could draw scrutiny regarding the company's compliance with reporting obligations.

Next Steps

• Momentus Inc. is required to file a Form 8-K disclosing this amendment by 9:30 a.m. New York City time on the trading day following December 23, 2025.
• Momentus will continue to have the right, but not the obligation, to direct Yield Point to purchase Put Shares under the amended terms during the Commitment Period.

Key Dates

Recommendation

The amendment to the equity purchase agreement, shifting to a discounted variable price and the waiver of the 10-Q filing, signals potential financial weakness and increased dilution risk for Momentus. While the agreement provides continued access to capital, the terms are less favorable. A 'hold' recommendation is appropriate for existing investors to monitor the company's ability to execute its business plan and address reporting delays, while new investors should exercise caution due to the heightened risks.

Keywords

Momentus, MNTS, Equity Purchase Agreement, Capital Raise, Share Dilution, Variable Price, SEC Filing, Yield Point, Form 8-K, Financing